Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic fever patients

Journal of Tropical Medicine

Volumn 2014, Issue , 2014, Pages

  Carvalho, Denise Maciel ^a   Garcia, Fernanda Gonçalves ^a   Terra, Ana Paula Sarreta ^a   Lopes Tosta, Ana Cristina ^a   Silva, Luciana De Almeida ^a   Castellano, Lúcio Roberto ^b   Silva Teixeira, David Nascimento ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; NITRIC OXIDE; NONSTRUCTURAL PROTEIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; MONOCYTE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE COUNT;

EID: 84919797949     PISSN: 16879686     EISSN: 16879694     Source Type: Journal    
DOI: 10.1155/2014/901276     Document Type: Article

References (46)

1. M. G. Guzman, S. B. Halstead, H. Artsob et al., "Dengue: a continuing global threat," Nature Reviews Microbiology, vol. 8, no. 12, pp. S7-S16, 2010
2. O. J. Brady, P. W. Gething, S. Bhatt et al., "Refining the global spatial limits of dengue virus transmission by evidence-based consensus," PLoS Neglected Tropical Diseases, vol. 6, no. 8, Article ID e1760, 2012
3. N. E. A. Murray, M. B. Quam, and A. Wilder-Smith, "Epidemiology of dengue: past, present and future prospects," Clinical Epidemiology, vol. 5, no. 1, pp. 299-309, 2013
4. J. G. Rigau-Pérez, G. G. Clark, D. J. Gubler, P. Reiter, E. J. Sanders, and A. V. Vorndam, "Dengue and dengue haemorrhagic fever," The Lancet, vol. 352, no. 9132, pp. 971-977, 1998
5. I. Kurane and F. E. Ennis, "Immunity and immunopathology in dengue virus infections," Seminars in Immunology, vol. 4, no. 2, pp. 121-127, 1992
6. M. G. Guzman and S. Vazquez, "The complexity of antibodydependent enhancement of dengue virus infection," Viruses, vol. 2, no. 12, pp. 2649-2662, 2010
7. I. Kurane, B. L. Innis, A. Nisalak et al., "Human T cell response to dengue virus antigens. Proliferative responses and interferon gamma production," The Journal of Clinical Investigation, vol. 83, no. 2, pp. 506-513, 1989
8. A. L. Rothman, "Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms," Nature Reviews Immunology, vol. 11, no. 8, pp. 532-543, 2011
9. A. L. Rothman and F. A. Ennis, "Immunopathogenesis of dengue hemorrhagic fever," Virology, vol. 257, no. 1,pp. 1-6, 1999
10. U. C. Chaturvedi, R. Agarwal, E. A. Elbishbishi, and A. S. Mustafa, "Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis," FEMS Immunology and Medical Microbiology, vol. 28, no. 3, pp. 183-188, 2000
11. S. Yacoub, J. Mongkolsapaya, and G. Screaton, "The pathogenesis of dengue," Current Opinion in Infectious Diseases, vol. 26, no. 3, pp. 284-289, 2013
12. R. M. Scott, A. Nisalak, U. Cheamudon, S. Seridhoranakul, and S. Nimmannitya, "Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever," Journal of Infectious Diseases, vol. 141, no. 1, pp. 1-6, 1980
13. W. C. Hall, T. P. Crowell, D. M. Watts et al., "Demonstration of yellow fever and dengue antigens in formalin-fixed paraffinembedded human liver by immunohistochemical analysis," The American Journal of Tropical Medicine and Hygiene, vol. 45, no. 4, pp. 408-417, 1991
14. K. Jessie, M. Y. Fong, S. Devi, S. K. Lam, and K. T. Wong, "Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization," Journal of Infectious Diseases, vol. 189, no. 8, pp. 1411-1418, 2004
15. E. L. A. Braga, P. Moura, L. M. O. Pinto et al., "Detection of circulant tumor necrosis factor-, soluble tumor necrosis factor p75 and interferon in Brazilian patients with dengue fever and dengue hemorrhagic fever,"Memorias do Instituto Oswaldo Cruz, vol. 96, no. 2, pp. 229-232, 2001
16. M. T. Fernández-Mestre, K. Gendzekhadze, P. Rivas-Vetencourt, and Z. Layrisse, "TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients," Tissue Antigens, vol. 64,no. 4, pp. 469-472, 2004
17. A. Chuansumrit, N. Anantasit, W. Sasanakul et al., "Tumour necrosis factor gene polymorphism in dengue infection: association with risk of bleeding," Paediatrics and International Child Health, vol. 33, no. 2, pp. 97-101, 2013
18. Y.-T. Yen, H.-C. Chen, Y.-D. Lin, C.-C. Shieh, and B. A. Wu-Hsieh, "Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development," Journal of Virology, vol. 82, no. 24, pp. 12312-12324, 2008
19. P. Marianneau, A.-M. Steffan, C. Royer et al., "Infection of primary cultures of human Kupffer cells by dengue virus: no viral progeny synthesis, but cytokine production is evident," Journal of Virology, vol. 73, no. 6, pp. 5201-5206, 1999
20. N. Valero, L. M. Espina,G. Añez, E. Torres, and J. A. Mosquera, "Short report: Increased level of serum nitric oxide in patients with dengue,"The American Journal of Tropical Medicine and Hygiene, vol. 66, no. 6, pp. 762-764, 2002
21. P. C. F. Neves-Souza, E. L. Azeredo, S. M. O. Zagne et al., "Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection," BMC Infectious Diseases, vol. 5, article 64, 2005
22. T. R. Kreil and M. M. Eibl, "Nitric oxide and viral infection: No antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo," Virology, vol. 219, no. 1, pp. 304-306, 1996
23. P. Nicotera, B. Brune, and G. Bagetta, "Nitric oxide: inducer or suppressor of apoptosis" Trends in Pharmacological Sciences, vol. 18, no. 6, pp. 189-190, 1997
24. G. Karupiah, Q. W. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. MacMicking, "Inhibition of viral replication by interferon-induced nitric oxide synthase," Science, vol. 261, no. 5127, pp. 1445-1448, 1993
25. M. Saura, C. Zaragoza, A. McMillan et al., "An antiviral mechanism of nitric oxide: inhibition of a viral protease," Immunity, vol. 10, no. 1, pp. 21-28, 1999
26. L. G. Guidotti and F. V. Chisari, "Noncytolytic control of viral infections by the innate and adaptive immune response," Annual Review of Immunology, vol. 19, pp. 65-91, 2001
27. A. G. Bowie and I. R. Haga, "Therole of Toll-like receptors in the host response to viruses," Molecular Immunology, vol. 42, no. 8, pp. 859-867, 2005
28. S.-Y. Zhang, E. Jouanguy, V. Sancho-Shimizu et al., "Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses," Immunological Reviews, vol. 220, no. 1, pp. 225-236, 2007
29. M. D. deKruif, T. E. Setiati, A. T. A. Mairuhu et al., "Differential gene expression changes in children with severe dengue virus infections," PLoSNeglected TropicalDiseases, vol. 2, no. 4, article e215, 2008
30. O. Takeuchi and S. Akira, "Innate immunity to virus infection," Immunological Reviews, vol. 227, no. 1, pp. 75-86, 2009
31. M. Essakalli, O. Atouf, N. Bennani, N. Benseffaj, S. Ouadghiri, and C. Brick, "Toll-like receptors," Pathologie Biologie, vol. 57, no. 5, pp. 430-438, 2009
32. Y.-C. Chen, S.-Y. Wang, and C.-C. King, "Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism," Journal of Virology, vol. 73, no. 4, pp. 2650-2657, 1999
33. A. C. Shurtleff, D. W. C. Beasley, J. J. Y. Chen et al., "Genetic variation in the 3 non-coding region of dengue viruses," Virology, vol. 281, no. 1, pp. 75-87, 2001
34. E. C. Holmes and S. S. Twiddy, "The origin, emergence and evolutionary genetics of dengue virus," Infection, Genetics and Evolution, vol. 3, no. 1, pp. 19-28, 2003
35. D. A. Muller and P. R. Young, "The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker," Antiviral Research, vol. 98, no. 2, pp. 192-208, 2013
36. WHO-Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, 2nd edition, 1997, http://www. who. int/csr/resources/ publications/dengue/Denguepublication/en
37. G. A. Macedo, M. L. C. Gonin, S. M. Pone, O. G. Cruz, F. F. Nobre, and P. Brasil, "Sensitivity and specificity of the World Health Organization dengue classification schemes for severe dengue assessment in children in Rio de Janeiro," PLoS ONE, vol. 9, no. 4, Article IDe96314, 2014
38. P. Avirutnan,N. Punyadee, S. Noisakran et al., "Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement," Journal of Infectious Diseases, vol. 193, no. 8, pp. 1078-1088, 2006
39. C.-F. Lin, H.-Y. Lei, A.-L. Shiau et al., "Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide,"TheJournal of Immunology, vol. 169, no. 2, pp. 657-664, 2002
40. P. Vallance and S. Moncada, "Nitric oxide-from mediator to medicines," Journal of the Royal College of Physicians of London, vol. 28, no. 3, pp. 209-219, 1994
41. W. C. Sessa, "The nitric oxide synthase family of proteins," Journal of Vascular Research, vol. 31, no. 3, pp. 131-143, 1994
42. A. Sanchez, M. Lukwiya, D. Bausch et al., "Analysis of human peripheral blood samples fromfatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels," Journal of Virology, vol. 78, no. 19, pp. 10370-10377, 2004
43. S. Mocellin, V. Bronte, and D. Nitti, "Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities," Medicinal Research Reviews, vol. 27, no. 3, pp. 317-352, 2007
44. A. Levy, N. Valero, L. M. Espina, G. Añez, J. Arias, and J. Mosquera, "Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue," Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 104, no. 1, pp. 16-23, 2010
45. J. D. Teo, P. A. Macary, and K. S. Tan, "Pleiotropic effects of Blastocystis spp. subtypes 4 and 7 on ligand-specific toll-like receptor signaling and NF B activation in a human monocyte cell line," PLoS ONE, vol. 9, no. 2,Article ID e89036, 2014
46. N. Modhiran, S. Kalayanarooj, and S. Ubol, "Subversion of innate defenses by the interplay between DENV and preexisting enhancing antibodies: TLRs signaling collapse," PLoS neglected tropical diseases, vol. 4, no. 12, article e924, 2010.